Trial intelligence / Profile preview

HZA106827: Fluticasone furoate plus vilanterol vs fluticasone furoate in persistent asthma

2010-019590-15Phase 3Completed

Sponsor
GSK
Start
Aug 2010
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of fluticasone propionate + vilanterol in asthma (2 arms), sponsored by GSK. Started Aug 2010; status: completed.

02

Drugs

fluticasone propionate + vilanterol
03

Conditions

asthma

Beyond the preview

Go deeper on 2010-019590-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019590-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call